BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31611144)

  • 1. Organoleptic excipients used in pediatric antibiotics.
    Nakama KA; Dos Santos RB; Serpa P; Maciel TR; Haas SE
    Arch Pediatr; 2019 Oct; 26(7):431-436. PubMed ID: 31611144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues in the formulation of drugs for oral use in children: role of excipients.
    Pawar S; Kumar A
    Paediatr Drugs; 2002; 4(6):371-9. PubMed ID: 12038873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical excipients and the information on drug labels.
    Balbani AP; Stelzer LB; Montovani JC
    Braz J Otorhinolaryngol; 2006; 72(3):400-6. PubMed ID: 17119779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mystery ingredients: sweeteners, flavorings, dyes, and preservatives in analgesic/antipyretic, antihistamine/decongestant, cough and cold, antidiarrheal, and liquid theophylline preparations.
    Kumar A; Rawlings RD; Beaman DC
    Pediatrics; 1993 May; 91(5):927-33. PubMed ID: 7682684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sweeteners, flavorings, and dyes in antibiotic preparations.
    Kumar A; Weatherly MR; Beaman DC
    Pediatrics; 1991 Mar; 87(3):352-60. PubMed ID: 2000275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of Organoleptic Agents in Pharmaceuticals and Cosmetics.
    Patil A; Bhide S; Bookwala M; Soneta B; Shankar V; Almotairy A; Almutairi M; Narasimha Murthy S
    AAPS PharmSciTech; 2018 Jan; 19(1):36-47. PubMed ID: 28900868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sweeteners, dyes, and other excipients in vitamin and mineral preparations.
    Kumar A; Aitas AT; Hunter AG; Beaman DC
    Clin Pediatr (Phila); 1996 Sep; 35(9):443-50. PubMed ID: 8877241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.
    Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C;
    Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basics: Excipients Used in Nonsterile Compounding, Part 2.
    Allen LV
    Int J Pharm Compd; 2019; 23(5):393-396. PubMed ID: 31513538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative and quantitative control of pediatric syrups using Nuclear Magnetic Resonance and chemometrics.
    Alves Filho EG; Silva LMA; Araújo NVP; Alves EG; Lião LM; Alcantara GB
    J Pharm Biomed Anal; 2018 May; 153():29-36. PubMed ID: 29459233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation development of paracetamol instant jelly for pediatric use.
    Almurisi SH; Doolaanea AA; Akkawi ME; Chatterjee B; Ahmed Saeed Aljapairai K; Islam Sarker MZ
    Drug Dev Ind Pharm; 2020 Aug; 46(8):1373-1383. PubMed ID: 32619118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavoring meds for children and adults so it goes down easy!
    Cabaleiro J
    Home Healthc Nurse; 2003 May; 21(5):295-8. PubMed ID: 12792409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative, Sugar-Free Oral Hydrogel as a Co-administrative Vehicle for Pediatrics: a Strategy to Enhance Patient Compliance.
    Pereira M; Silva FC; Simões S; Ribeiro HM; Almeida AJ; Marto J
    AAPS PharmSciTech; 2022 Apr; 23(4):107. PubMed ID: 35381882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of ethanol and other potentially harmful excipients in pediatric oral medicines: survey of community pharmacies in a Nigerian City.
    Soremekun R; Ogbuefi I; Aderemi-Williams R
    BMC Res Notes; 2019 Jul; 12(1):460. PubMed ID: 31349864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric drugs--a review of commercially available oral formulations.
    Strickley RG; Iwata Q; Wu S; Dahl TC
    J Pharm Sci; 2008 May; 97(5):1731-74. PubMed ID: 17823956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palatability of pediatric formulations: do rats predict aversiveness?
    Simões S; Almeida AJ; Marto J
    Drug Dev Ind Pharm; 2021 Jul; 47(7):1121-1126. PubMed ID: 34545750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues impacting therapeutic outcomes in pediatric patients: an overview.
    Kalra A; Goindi S
    Curr Pediatr Rev; 2014; 10(3):184-93. PubMed ID: 25088338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review.
    van Riet-Nales DA; Schobben AF; Egberts TC; Rademaker CM
    Clin Ther; 2010 May; 32(5):924-38. PubMed ID: 20685501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excipients and additives: hidden hazards in drug products and in product substitution.
    Napke E; Stevens DG
    Can Med Assoc J; 1984 Dec; 131(12):1449-52. PubMed ID: 6498699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A High-Demanding Strategy to Ensure the Highest Quality Standards of Oral Liquid Individualized Medicines for Pediatric Use.
    Suárez-González J; Santoveña-Estévez A; Armijo-Ruíz S; Castillo A; Fariña JB
    AAPS PharmSciTech; 2019 Jun; 20(5):208. PubMed ID: 31161450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.